May Health, a medical device company dedicated to helping women living with polycystic ovary syndrome (PCOS), today announced ...

May Health’s Anavi™ System enables a one-time, office-based procedure intended to restore ovulation in women with PCOS-related infertility who do not respond to first-line therapies May Health, a ...

Nexpring Health, a global leader in assisted reproductive technology (ART) solutions, today announced a strategic investment in May Health, a medical device company pioneering a novel treatment ...

Please provide your email address to receive an email when new articles are posted on . The most common reason women with PCOS struggle to conceive is irregular and unpredictable ovulation, not ...

Polycystic ovary syndrome (PCOS) is a lifelong endocrine disorder that affects 10% of women around the world, and can cause excess body hair, weight gain, acne or oily skin, and baldness or thinning ...

May 14, 2024, 10:13am EDT Updated: May 15, 2024, 7:21am EDT Anastasiia Sapon Anne Morrissey, CEO of May Health Clinical-stage medical device company May Health has closed a $25 million Series B ...

In addition to their origins as treatment for type 2 diabetes, GLP-1 receptor agonists like Ozempic and Wegovy are often most closely associated with obesity and weight loss. But did you know these ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Never miss an episode of Living Well with Alison Starling ...

In PCOS-related fertility, the focus is not just ovulation – it is insulin balance, inflammation control, and better hormonal ...

Polycystic ovary syndrome (PCOS), the most common hormonal disorder among women of reproductive age, affects an estimated 8%-13% of women worldwide. Once viewed primarily as a reproductive disorder, ...